Jump-Start on Slow Trek to Treatment for a Disease
26545
The search for new treatments can be tricky when the disease is fearsome but nearly forgotten because its victims are poor and obscure.
596966
Researchers have hit on what may be an inexpensive way to prevent death from infections in children with HIV until anti-retroviral drugs become affordable in the developing world.
653673
A new drug that can treat patients with multiple sclerosis has been approved by the Food and Drug Administration but the high cost of the medication has some people concerned.
137113
Tuberculosis may reach the point where most new cases in some countries are resistant to many drugs unless far greater efforts are made now.
328372
A  discovery could lead to drugs to treat a 'forgotten' tropical disease, scientists hope.
511170
Now might be a great time to load up on cutting-edge drugmakers.
738382
The drug maker is poised to speed past its rivals.
468484
Importing cheaper drugs from up north isn't as simple as it seems
506148
It's running trials to see if the drug can be used in earlier stages of cancer.
562642
By Hanah Cho, The Baltimore Sun  Sep. 17--At St. Agnes Hospital in Baltimore, heart attack patients are receiving faster treatment.
445640
Scientists have taken an important step towards a new way of treating disease by switching off key genes.
418289
A heart patient who had muscle cells transferred from his leg to his heart makes good progress.
425170
Faced with weak development pipelines that are putting a drag on stock prices, drug manufacturers are retooling the decades-old system of clinical trials to make it faster and cheaper.
156434
An experimental cancer drug made by Abbott Laboratories Inc. passed its first round of human testing about six months faster than usual, thanks to a new program that aims to speed drug development.
254957
Scientists have identified a way of tackling hard-to-treat breast cancers.
454613
This new blood pressure treatment has been developed in fits and starts.
232794
By Tampone, Kevin  CICERO - Cancer research is daunting for a variety of reasons, not the least of which is the massive number of substances that might be effective in future drugs.